Qintar M, et al. - Using a 12-center registry, researchers assessed long-term health status in relation to de-escalation of antianginal medications (AAMs) following chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in consecutive patients. Using the Seattle Angina Questionnaire and the Rose Dyspnea Scale, evaluation of health status was done at 6 months following successful CTO PCI. According to the findings, nearly one-third of patients had de-escalation of AAMs at 1 month in this study population of 669 patients with successful CTO PCI. They found that de-escalation of AAMs was not related to worse long-term health status, including increased risk of angina or dyspnea.